Emerging treatments
Niacinamide
Oral niacinamide may be effective in reducing the development of cutaneous SCCs.[73] Evidence suggests that chemoprevention using oral niacinamide reduced the occurrence of new non-melanoma skin cancer in high risk patients, and reduced the risk of skin cancer in healthy patients or organ transplant patients with a history of cutaneous SCC.[129][130] However, when a systematic review pooled immunocompetent and immunosuppressed patients, it found insufficient evidence that oral niacinamide therapy reduced the number of keratinocyte cancers.[131]
Use of this content is subject to our disclaimer